Medliminal Revenue and Competitors
Estimated Revenue & Valuation
- Medliminal's estimated annual revenue is currently $4.1M per year.
- Medliminal's estimated revenue per employee is $112,000
Employee Data
- Medliminal has 37 Employees.
- Medliminal grew their employee count by -18% last year.
Medliminal's People
Name | Title | Email/Phone |
---|---|---|
1 | IT Director | Reveal Email/Phone |
2 | Nurse Audit Specialist | Reveal Email/Phone |
Medliminal Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.8M | 34 | 3% | N/A | N/A |
#2 | $13.7M | 98 | 10% | $15M | N/A |
#3 | $6.8M | 54 | 64% | N/A | N/A |
#4 | $4.1M | 37 | -18% | N/A | N/A |
#5 | $69.9M | 393 | -4% | $0.03B | N/A |
#6 | $9.2M | 73 | 3% | N/A | N/A |
#7 | $2.4M | 24 | -4% | N/A | N/A |
#8 | $11.5M | 82 | -22% | $61M | N/A |
#9 | $16.4M | 117 | 56% | N/A | N/A |
#10 | $0.8M | 10 | -9% | N/A | N/A |
What Is Medliminal?
Medliminal Identifies billing errors on medical bills. The cost of medical care is a major part of our national economy and is one of the most important cost issues in our lives. Medliminal specializes in medical cost containment and offers our clients focused and innovative solutions and services through our award-winning Artificial Intelligence, known as H-CATâ„¢, designed to reduce healthcare costs to all payers on a national level.
keywords:N/AN/A
Total Funding
37
Number of Employees
$4.1M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medliminal News
2022-04-13 - Washington Commanders announce new partnership with iHeartMedia
"Medliminal will not be continuing its partnership with the Washington Commanders for the 2022-2023 season and indefinitely going forward,"...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.8M | 37 | 6% | N/A |
#2 | $7.3M | 37 | 12% | N/A |
#3 | $3M | 38 | 9% | N/A |
#4 | $8.8M | 38 | -7% | N/A |
#5 | $4.4M | 38 | 3% | N/A |